Clarus Wealth Advisors’s Precigen PGEN Stock Holding History

Clarus Wealth Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-300	Closed	-$5K	–	711
2018 Q3	$5K	Buy	+300	New	+$4.46K	﹤0.01%	614

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clarus Wealth Advisors's PGEN Position: Q4 2018 in Review

Clarus Wealth Advisors sold out of Precigen (PGEN) in Q4 2018, closing a stake of 300 shares — an estimated $5K sold.

Clarus Wealth Advisors first reported a position in PGEN in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q4 2018.

Clarus Wealth Advisors reported no remaining Precigen position as of Q4 2018 after selling out during the quarter.
Clarus Wealth Advisors sold 300 Precigen shares in Q4 2018, an estimated $5K.
Clarus Wealth Advisors first reported a position in Precigen in Q3 2018 and held it in 1 quarter.
Clarus Wealth Advisors's Precigen position peaked at $5K in Q3 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q4 2018.

Based on Clarus Wealth Advisors's 13F filing for Q4 2018, filed 7 Jan 2019.